Skip to main content
6x
Patients achieved 36% and 40% treatment success* in the VTAMA cream arms vs 6% and 6% in the vehicle arms in PSOARING 1 and 2 pivotal studies1
*Treatment success: PGA score of 0 or 1 and ≥2-grade improvement from baseline at week 12.6
VTAMA CREAM DEMONSTRATED CLEARER SKIN OVER 12 WEEKS
In two identical studies, VTAMA cream showed significant results vs vehicle at week 4 with improvements continuing over 12 weeks1,7-9
Potential female patient who may be prescribed VTAMA®
Potential female patient who may be prescribed VTAMA®
Not an actual patient
PGA treatment success: PGA Score of 0 or 1 and ≥2-grade improvement from baseline to week 121,6-8
VTAMA CREAM delivered significant PASI75 rates as early as week 4, with continued improvement through week 129
At week 12, up to 48% of VTAMA cream patients achieved PASI75 vs ~10% of those using vehicle9
Clipboard with a graph of a positive trendline
Clipboard with a graph of a positive trendline
PASI75 from Baseline to week 127-9
Not an actual patient
SEE SIGNIFICANT RESULTS FROM PATIENTS IN VTAMA CREAM CLINICAL studies
VTAMA cream helped adult patients with mild, moderate, and severe plaque psoriasis achieve clearer skin.

Click on each section of the body to view the results. Please note, the photographs you will see are representative of one target lesion on individual patients treated with VTAMA cream during the clinical studies.

Back to top